{"id":"https://openalex.org/W2064616786","doi":"https://doi.org/10.1097/00008390-200512000-00007","title":"Somatostatin receptor scintigraphy with 111In-DOTA-lanreotide and 111In-DOTA-Tyr3-octreotide in patients with stage IV melanoma: in-vitro and in-vivo results","display_name":"Somatostatin receptor scintigraphy with 111In-DOTA-lanreotide and 111In-DOTA-Tyr3-octreotide in patients with stage IV melanoma: in-vitro and in-vivo results","publication_year":2005,"publication_date":"2005-11-24","ids":{"openalex":"https://openalex.org/W2064616786","doi":"https://doi.org/10.1097/00008390-200512000-00007","mag":"2064616786","pmid":"https://pubmed.ncbi.nlm.nih.gov/16314738"},"language":"en","primary_location":{"id":"doi:10.1097/00008390-200512000-00007","doi":"https://doi.org/10.1097/00008390-200512000-00007","is_oa":false,"landing_page_url":"https://doi.org/10.1097/00008390-200512000-00007","pdf_url":null,"source":{"id":"https://openalex.org/S3207524","display_name":"Melanoma Research","issn_l":"0960-8931","issn":["0960-8931","1473-5636"],"is_oa":false,"is_in_doaj":false,"is_core":true,"listed_in":["anvur-scientific","cwts-core","dongbi-c","jufo-1","ki-jl-1","medline","norway-1","poland-100","russia-white-list-1","vabb-shw"],"host_organization":"https://openalex.org/P4310315671","host_organization_name":"Lippincott Williams & Wilkins","host_organization_lineage":["https://openalex.org/P4310315671","https://openalex.org/P4310318547"],"host_organization_lineage_names":["Lippincott Williams & Wilkins","Wolters Kluwer"],"type":"journal"},"license":null,"license_id":null,"version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"Melanoma Research","raw_type":"journal-article"},"volume":null,"type":"article","is_traditional":true,"indexed_in":["crossref","pubmed"],"open_access":{"is_oa":false,"oa_status":"closed","oa_url":null,"any_repository_has_fulltext":false},"authorships":[{"author_position":"first","author":{"id":"https://openalex.org/A5060699000","display_name":"Julia Valencak","orcid":"https://orcid.org/0000-0003-4737-2920","observed_orcids":["https://orcid.org/0000-0003-4737-2920"]},"institutions":[{"id":"https://openalex.org/I76134821","display_name":"Medical University of Vienna","ror":"https://ror.org/05n3x4p02","country_code":"AT","type":"education","lineage":["https://openalex.org/I76134821"]}],"countries":["AT"],"is_corresponding":true,"raw_author_name":"Julia Valencak","raw_affiliation_strings":["Department of Dermatology, Medical University of Vienna, Vienna, Austria. julia.valencak@meduniwien.ac.at","Dermatology","requests for reprints to Julia Valencak MD, Division of General Dermatology, Department of Dermatology, Medical University of Vienna, W\u00e4hringer G\u00fcrtel 18\u201320, A-1090 Wien, Austria"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Department of Dermatology, Medical University of Vienna, Vienna, Austria. julia.valencak@meduniwien.ac.at","institution_ids":["https://openalex.org/I76134821"]},{"raw_affiliation_string":"Dermatology","institution_ids":[]},{"raw_affiliation_string":"requests for reprints to Julia Valencak MD, Division of General Dermatology, Department of Dermatology, Medical University of Vienna, W\u00e4hringer G\u00fcrtel 18\u201320, A-1090 Wien, Austria","institution_ids":["https://openalex.org/I76134821"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5002174658","display_name":"Elisabeth Heere\u2010Ress","orcid":null,"observed_orcids":[]},"institutions":[],"countries":[],"is_corresponding":false,"raw_author_name":"Elisabeth Heere-Ress","raw_affiliation_strings":["Dermatology"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Dermatology","institution_ids":[]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5015140066","display_name":"Tatjana Traub\u2010Weidinger","orcid":"https://orcid.org/0000-0003-1118-926X","observed_orcids":["https://orcid.org/0000-0003-1118-926X"]},"institutions":[],"countries":[],"is_corresponding":false,"raw_author_name":"Tatjana Traub-Weidinger","raw_affiliation_strings":["Nuclear Medicine"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Nuclear Medicine","institution_ids":[]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5108094298","display_name":"Markus Raderer","orcid":null,"observed_orcids":[]},"institutions":[],"countries":[],"is_corresponding":false,"raw_author_name":"Markus Raderer","raw_affiliation_strings":["Internal Medicine I, Division of Oncology"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Internal Medicine I, Division of Oncology","institution_ids":[]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5006122717","display_name":"Achim Schneeberger","orcid":"https://orcid.org/0009-0003-9410-124X","observed_orcids":["https://orcid.org/0009-0003-9410-124X"]},"institutions":[],"countries":[],"is_corresponding":false,"raw_author_name":"Achim Schneeberger","raw_affiliation_strings":["Dermatology"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Dermatology","institution_ids":[]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5111524797","display_name":"Theresia Thalhammer","orcid":null,"observed_orcids":[]},"institutions":[{"id":"https://openalex.org/I76134821","display_name":"Medical University of Vienna","ror":"https://ror.org/05n3x4p02","country_code":"AT","type":"education","lineage":["https://openalex.org/I76134821"]}],"countries":["AT"],"is_corresponding":false,"raw_author_name":"Theresia Thalhammer","raw_affiliation_strings":["Pathophysiology, Medical University of Vienna, Vienna"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Pathophysiology, Medical University of Vienna, Vienna","institution_ids":["https://openalex.org/I76134821"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5061397890","display_name":"Sylvia Aust","orcid":null,"observed_orcids":[]},"institutions":[{"id":"https://openalex.org/I76134821","display_name":"Medical University of Vienna","ror":"https://ror.org/05n3x4p02","country_code":"AT","type":"education","lineage":["https://openalex.org/I76134821"]}],"countries":["AT"],"is_corresponding":true,"raw_author_name":"Sylvia Aust","raw_affiliation_strings":["Pathophysiology, Medical University of Vienna, Vienna"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Pathophysiology, Medical University of Vienna, Vienna","institution_ids":["https://openalex.org/I76134821"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5019973974","display_name":"Gerhard Hamilton","orcid":"https://orcid.org/0000-0002-4038-5182","observed_orcids":["https://orcid.org/0000-0002-4038-5182"]},"institutions":[],"countries":[],"is_corresponding":false,"raw_author_name":"Gerhard Hamilton","raw_affiliation_strings":["Ludwig Boltzmann Institute of Clinical Oncology, Vienna"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Ludwig Boltzmann Institute of Clinical Oncology, Vienna","institution_ids":[]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5064747758","display_name":"Irene Johanna Virgolini","orcid":"https://orcid.org/0000-0001-7097-6170","observed_orcids":["https://orcid.org/0000-0001-7097-6170"]},"institutions":[{"id":"https://openalex.org/I143397708","display_name":"Innsbruck Medical University","ror":"https://ror.org/03pt86f80","country_code":"AT","type":"education","lineage":["https://openalex.org/I143397708"]},{"id":"https://openalex.org/I190249584","display_name":"Universit\u00e4t Innsbruck","ror":"https://ror.org/054pv6659","country_code":"AT","type":"education","lineage":["https://openalex.org/I190249584"]}],"countries":["AT"],"is_corresponding":false,"raw_author_name":"Irene Virgolini","raw_affiliation_strings":["Department of Nuclear Medicine, Medical University of Innsbruck, Innsbruck, Austria"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Department of Nuclear Medicine, Medical University of Innsbruck, Innsbruck, Austria","institution_ids":["https://openalex.org/I143397708","https://openalex.org/I190249584"]}]},{"author_position":"last","author":{"id":"https://openalex.org/A5112026684","display_name":"Hubert Pehamberger","orcid":null,"observed_orcids":[]},"institutions":[],"countries":[],"is_corresponding":false,"raw_author_name":"Hubert Pehamberger","raw_affiliation_strings":["Dermatology"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Dermatology","institution_ids":[]}]}],"institutions":[],"countries_distinct_count":1,"institutions_distinct_count":3,"corresponding_author_ids":["https://openalex.org/A5060699000","https://openalex.org/A5061397890"],"corresponding_institution_ids":["https://openalex.org/I76134821"],"apc_list":null,"apc_paid":null,"fwci":0.2152,"has_fulltext":false,"cited_by_count":12,"citation_normalized_percentile":{"value":0.60477542,"is_in_top_1_percent":false,"is_in_top_10_percent":false},"cited_by_percentile_year":{"min":87,"max":95},"biblio":{"volume":"15","issue":"6","first_page":"523","last_page":"529"},"is_retracted":false,"is_paratext":false,"is_xpac":false,"primary_topic":{"id":"https://openalex.org/T11395","display_name":"Radiopharmaceutical Chemistry and Applications","score":0.5282999873161316,"subfield":{"id":"https://openalex.org/subfields/2741","display_name":"Radiology, Nuclear Medicine and Imaging"},"field":{"id":"https://openalex.org/fields/27","display_name":"Medicine"},"domain":{"id":"https://openalex.org/domains/4","display_name":"Health Sciences"}},"topics":[{"id":"https://openalex.org/T11395","display_name":"Radiopharmaceutical Chemistry and Applications","score":0.5282999873161316,"subfield":{"id":"https://openalex.org/subfields/2741","display_name":"Radiology, Nuclear Medicine and Imaging"},"field":{"id":"https://openalex.org/fields/27","display_name":"Medicine"},"domain":{"id":"https://openalex.org/domains/4","display_name":"Health Sciences"}},{"id":"https://openalex.org/T10754","display_name":"Neuroendocrine Tumor Research Advances","score":0.4171999990940094,"subfield":{"id":"https://openalex.org/subfields/2730","display_name":"Oncology"},"field":{"id":"https://openalex.org/fields/27","display_name":"Medicine"},"domain":{"id":"https://openalex.org/domains/4","display_name":"Health Sciences"}},{"id":"https://openalex.org/T10522","display_name":"Medical Imaging Techniques and Applications","score":0.023399999365210533,"subfield":{"id":"https://openalex.org/subfields/2741","display_name":"Radiology, Nuclear Medicine and Imaging"},"field":{"id":"https://openalex.org/fields/27","display_name":"Medicine"},"domain":{"id":"https://openalex.org/domains/4","display_name":"Health Sciences"}}],"keywords":[{"id":"https://openalex.org/keywords/somatostatin-receptor-scintigraphy","display_name":"somatostatin receptor scintigraphy","score":0.9559999704360962},{"id":"https://openalex.org/keywords/lanreotide","display_name":"lanreotide","score":0.8640000224113464},{"id":"https://openalex.org/keywords/octreotide","display_name":"octreotide","score":0.8690000176429749},{"id":"https://openalex.org/keywords/somatostatin-receptor-expression","display_name":"somatostatin receptor expression","score":0.7070000171661377},{"id":"https://openalex.org/keywords/metastatic-melanoma","display_name":"metastatic melanoma","score":0.890999972820282},{"id":"https://openalex.org/keywords/tumor-imaging","display_name":"tumor imaging","score":0.6129999756813049},{"id":"https://openalex.org/keywords/antiproliferative-activity","display_name":"antiproliferative activity","score":0.8460000157356262},{"id":"https://openalex.org/keywords/melanoma-cell-lines","display_name":"melanoma cell lines","score":0.9269999861717224},{"id":"https://openalex.org/keywords/immune-cells","display_name":"immune cells","score":0.7749999761581421}],"concepts":[{"id":"https://openalex.org/C2779609023","wikidata":"https://www.wikidata.org/wiki/Q1707877","display_name":"Lanreotide","level":5,"score":0.7527768611907959},{"id":"https://openalex.org/C2779931791","wikidata":"https://www.wikidata.org/wiki/Q161515","display_name":"DOTA","level":3,"score":0.6693629026412964},{"id":"https://openalex.org/C2777658100","wikidata":"https://www.wikidata.org/wiki/Q180614","display_name":"Melanoma","level":2,"score":0.5911475419998169},{"id":"https://openalex.org/C80115893","wikidata":"https://www.wikidata.org/wiki/Q2067077","display_name":"Somatostatin receptor","level":3,"score":0.5890737771987915},{"id":"https://openalex.org/C2776297358","wikidata":"https://www.wikidata.org/wiki/Q407166","display_name":"Somatostatin","level":2,"score":0.579458475112915},{"id":"https://openalex.org/C71924100","wikidata":"https://www.wikidata.org/wiki/Q11190","display_name":"Medicine","level":0,"score":0.543686032295227},{"id":"https://openalex.org/C207001950","wikidata":"https://www.wikidata.org/wiki/Q141124","display_name":"In vivo","level":2,"score":0.5244115591049194},{"id":"https://openalex.org/C2781025020","wikidata":"https://www.wikidata.org/wiki/Q419935","display_name":"Octreotide","level":3,"score":0.5190999507904053},{"id":"https://openalex.org/C502942594","wikidata":"https://www.wikidata.org/wiki/Q3421914","display_name":"Cancer research","level":1,"score":0.4940667450428009},{"id":"https://openalex.org/C2779902710","wikidata":"https://www.wikidata.org/wiki/Q1130465","display_name":"Scintigraphy","level":2,"score":0.4531630575656891},{"id":"https://openalex.org/C126322002","wikidata":"https://www.wikidata.org/wiki/Q11180","display_name":"Internal medicine","level":1,"score":0.42565304040908813},{"id":"https://openalex.org/C202751555","wikidata":"https://www.wikidata.org/wiki/Q221681","display_name":"In vitro","level":2,"score":0.412993848323822},{"id":"https://openalex.org/C143998085","wikidata":"https://www.wikidata.org/wiki/Q162555","display_name":"Oncology","level":1,"score":0.34436312317848206},{"id":"https://openalex.org/C134018914","wikidata":"https://www.wikidata.org/wiki/Q162606","display_name":"Endocrinology","level":1,"score":0.33297136425971985},{"id":"https://openalex.org/C2989005","wikidata":"https://www.wikidata.org/wiki/Q214963","display_name":"Nuclear medicine","level":1,"score":0.3270336985588074},{"id":"https://openalex.org/C185592680","wikidata":"https://www.wikidata.org/wiki/Q2329","display_name":"Chemistry","level":0,"score":0.3160989284515381},{"id":"https://openalex.org/C86803240","wikidata":"https://www.wikidata.org/wiki/Q420","display_name":"Biology","level":0,"score":0.1150519847869873},{"id":"https://openalex.org/C2777433750","wikidata":"https://www.wikidata.org/wiki/Q189580","display_name":"Acromegaly","level":4,"score":0.09261831641197205},{"id":"https://openalex.org/C71315377","wikidata":"https://www.wikidata.org/wiki/Q11364","display_name":"Hormone","level":2,"score":0.0},{"id":"https://openalex.org/C55493867","wikidata":"https://www.wikidata.org/wiki/Q7094","display_name":"Biochemistry","level":1,"score":0.0},{"id":"https://openalex.org/C2984496839","wikidata":"https://www.wikidata.org/wiki/Q29956617","display_name":"Growth hormone","level":3,"score":0.0},{"id":"https://openalex.org/C150903083","wikidata":"https://www.wikidata.org/wiki/Q7108","display_name":"Biotechnology","level":1,"score":0.0}],"mesh":[{"descriptor_ui":"D000328","descriptor_name":"Adult","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D000368","descriptor_name":"Aged","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D005260","descriptor_name":"Female","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D006571","descriptor_name":"Heterocyclic Compounds","qualifier_ui":"Q000493","qualifier_name":"pharmacokinetics","is_major_topic":true},{"descriptor_ui":"D006801","descriptor_name":"Humans","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D007205","descriptor_name":"Indium Radioisotopes","qualifier_ui":null,"qualifier_name":null,"is_major_topic":true},{"descriptor_ui":"D008297","descriptor_name":"Male","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D008545","descriptor_name":"Melanoma","qualifier_ui":"Q000000981","qualifier_name":"diagnostic imaging","is_major_topic":true},{"descriptor_ui":"D008545","descriptor_name":"Melanoma","qualifier_ui":"Q000378","qualifier_name":"metabolism","is_major_topic":false},{"descriptor_ui":"D008545","descriptor_name":"Melanoma","qualifier_ui":"Q000473","qualifier_name":"pathology","is_major_topic":false},{"descriptor_ui":"D008875","descriptor_name":"Middle Aged","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D009367","descriptor_name":"Neoplasm Staging","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D010456","descriptor_name":"Peptides, Cyclic","qualifier_ui":"Q000493","qualifier_name":"pharmacokinetics","is_major_topic":true},{"descriptor_ui":"D011877","descriptor_name":"Radionuclide Imaging","qualifier_ui":"Q000379","qualifier_name":"methods","is_major_topic":false},{"descriptor_ui":"D014407","descriptor_name":"Tumor Cells, Cultured","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D015282","descriptor_name":"Octreotide","qualifier_ui":"Q000031","qualifier_name":"analogs & derivatives","is_major_topic":true},{"descriptor_ui":"D015282","descriptor_name":"Octreotide","qualifier_ui":"Q000493","qualifier_name":"pharmacokinetics","is_major_topic":false},{"descriptor_ui":"D015282","descriptor_name":"Octreotide","qualifier_ui":"Q000737","qualifier_name":"chemistry","is_major_topic":false},{"descriptor_ui":"D017481","descriptor_name":"Receptors, Somatostatin","qualifier_ui":"Q000378","qualifier_name":"metabolism","is_major_topic":true},{"descriptor_ui":"D019275","descriptor_name":"Radiopharmaceuticals","qualifier_ui":"Q000493","qualifier_name":"pharmacokinetics","is_major_topic":false},{"descriptor_ui":"D045744","descriptor_name":"Cell Line, Tumor","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false}],"locations_count":2,"locations":[{"id":"doi:10.1097/00008390-200512000-00007","doi":"https://doi.org/10.1097/00008390-200512000-00007","is_oa":false,"landing_page_url":"https://doi.org/10.1097/00008390-200512000-00007","pdf_url":null,"source":{"id":"https://openalex.org/S3207524","display_name":"Melanoma Research","issn_l":"0960-8931","issn":["0960-8931","1473-5636"],"is_oa":false,"is_in_doaj":false,"is_core":true,"listed_in":["anvur-scientific","cwts-core","dongbi-c","jufo-1","ki-jl-1","medline","norway-1","poland-100","russia-white-list-1","vabb-shw"],"host_organization":"https://openalex.org/P4310315671","host_organization_name":"Lippincott Williams & Wilkins","host_organization_lineage":["https://openalex.org/P4310315671","https://openalex.org/P4310318547"],"host_organization_lineage_names":["Lippincott Williams & Wilkins","Wolters Kluwer"],"type":"journal"},"license":null,"license_id":null,"version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"Melanoma Research","raw_type":"journal-article"},{"id":"pmid:16314738","doi":null,"is_oa":false,"landing_page_url":"https://pubmed.ncbi.nlm.nih.gov/16314738","pdf_url":null,"source":{"id":"https://openalex.org/S4306525036","display_name":"PubMed","issn_l":null,"issn":null,"is_oa":false,"is_in_doaj":false,"is_core":false,"listed_in":[],"host_organization":"https://openalex.org/I1299303238","host_organization_name":"National Institutes of Health","host_organization_lineage":["https://openalex.org/I1299303238"],"host_organization_lineage_names":[],"type":"repository"},"license":null,"license_id":null,"version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"Melanoma research","raw_type":"Journal Article"}],"best_oa_location":null,"sustainable_development_goals":[{"score":0.98580002784729,"id":"https://metadata.un.org/sdg/3","display_name":"Good health and well-being"}],"study_designs":[{"id":"https://openalex.org/study-designs/observational-study","display_name":"Observational Study"}],"awards":[],"funders":[],"has_content":{"pdf":false,"grobid_xml":false},"content_urls":null,"referenced_works_count":35,"referenced_works":["https://openalex.org/W1506672678","https://openalex.org/W1584743295","https://openalex.org/W1965010394","https://openalex.org/W1975027926","https://openalex.org/W1988783854","https://openalex.org/W1998767852","https://openalex.org/W2008677826","https://openalex.org/W2014155093","https://openalex.org/W2021468949","https://openalex.org/W2025242896","https://openalex.org/W2026592280","https://openalex.org/W2029891973","https://openalex.org/W2030825014","https://openalex.org/W2033001752","https://openalex.org/W2038120557","https://openalex.org/W2041786670","https://openalex.org/W2060305272","https://openalex.org/W2071310612","https://openalex.org/W2072675860","https://openalex.org/W2075408399","https://openalex.org/W2088693719","https://openalex.org/W2113754606","https://openalex.org/W2116218122","https://openalex.org/W2122132160","https://openalex.org/W2131690895","https://openalex.org/W2144917300","https://openalex.org/W2148430251","https://openalex.org/W2151100586","https://openalex.org/W2151254641","https://openalex.org/W2155161822","https://openalex.org/W2415183654","https://openalex.org/W2416544234","https://openalex.org/W3150545171","https://openalex.org/W4210992659","https://openalex.org/W4236261099"],"related_works":["https://openalex.org/W2030575325","https://openalex.org/W2144917300","https://openalex.org/W2122132160","https://openalex.org/W4242846611","https://openalex.org/W2011967393","https://openalex.org/W2014155093","https://openalex.org/W7098197284","https://openalex.org/W7099405724","https://openalex.org/W2731501530","https://openalex.org/W1966207668"],"abstract_inverted_index":{"The":[0,25],"overexpression":[1],"of":[2,18,27,36,57,64,67,83,100,124,139,165,172,178,199],"somatostatin":[3],"receptors":[4],"(SST-Rs)":[5],"on":[6,69,130,154,183,203],"various":[7],"tumour":[8,34,184],"cells":[9],"provides":[10],"the":[11,15,28,33,53,65,101,122,137,163],"molecular":[12],"basis":[13],"for":[14],"successful":[16],"use":[17],"radiolabelled":[19],"SST":[20,58,125,140,179],"analogues":[21,126,141,180],"in":[22,43,121,168],"clinical":[23],"oncology.":[24],"objective":[26],"study":[29],"was":[30,134],"to":[31,142,176,181],"evaluate":[32],"binding":[35,177],"In-1,4,7,10-tetraazacyclo-dodecane-N,N',N'',N'''-tetraacetic":[37],"acid-lanreotide":[38],"(In-DOTA-LAN)":[39],"and":[40,108,127],"In-DOTA-tyrosine-octreotide":[41],"(In-DOTA-Tyr-OCT)":[42],"patients":[44,75],"with":[45,61,76,90,136],"stage":[46],"IV":[47],"melanoma.":[48],"In":[49,113,145],"addition,":[50,146],"we":[51],"evaluated":[52],"potential":[54],"antiproliferative":[55],"effect":[56],"analogues,":[59],"together":[60],"an":[62],"assessment":[63],"functionality":[66],"SST-Rs,":[68],"four":[70],"melanoma":[71,79,167,204],"cell":[72,115,131,156],"lines.":[73,157],"Twenty-three":[74],"advanced":[77],"metastatic":[78,166],"underwent":[80],"scintigraphy.":[81],"Thirty-eight":[82],"61":[84],"lesions":[85,104],"(62%)":[86],"were":[87,95,106,111],"positively":[88],"imaged":[89],"In-DOTA-LAN,":[91],"whereas":[92],"23":[93,102],"(37%)":[94],"negative.":[96,112],"With":[97],"In-DOTA-Tyr-OCT,":[98],"10":[99],"documented":[103],"(43%)":[105],"positive":[107],"13":[109],"(56%)":[110],"vitro,":[114],"lines":[116],"showed":[117],"no":[118,128,147,197],"growth":[119],"inhibition":[120],"presence":[123],"influence":[129],"cycle":[132],"distribution":[133],"found":[135],"addition":[138],"cultured":[143],"cells.":[144,189,205],"functional":[148,200],"surface":[149],"SST-Rs":[150,182],"could":[151],"be":[152],"demonstrated":[153],"these":[155],"Taken":[158],"together,":[159],"our":[160,192],"results":[161],"demonstrate":[162],"visualization":[164],"a":[169],"high":[170],"percentage":[171],"patients,":[173],"probably":[174],"due":[175],"vessels":[185],"or":[186],"infiltrating":[187],"immune":[188],"Judging":[190],"from":[191],"data,":[193],"however,":[194],"there":[195],"is":[196],"evidence":[198],"SST-R":[201],"expression":[202]},"counts_by_year":[{"year":2026,"cited_by_count":1},{"year":2024,"cited_by_count":1},{"year":2021,"cited_by_count":1},{"year":2017,"cited_by_count":1},{"year":2015,"cited_by_count":1},{"year":2014,"cited_by_count":1},{"year":2013,"cited_by_count":1},{"year":2012,"cited_by_count":2}],"updated_date":"2026-11-07T11:25:07.637180","created_date":"2016-06-24T00:00:00"}